Correlation Between GlaxoSmithKline PLC and Roche Holding

Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Roche Holding Ltd, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Roche Holding.

Diversification Opportunities for GlaxoSmithKline PLC and Roche Holding

0.77

Correlation Coefficient

GlaxoSmithKline PLC  Roche Holding

Poor diversification

The 3 months correlation between GlaxoSmithKline and Roche is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Roche Holding go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Roche Holding

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Roche Holding. In addition to that, GlaxoSmithKline PLC is 1.05 times more volatile than Roche Holding Ltd. It trades about -0.24 of its total potential returns per unit of risk. Roche Holding Ltd is currently generating about -0.14 per unit of volatility. If you would invest  4,116  in Roche Holding Ltd on September 3, 2024 and sell it today you would lose (492.00) from holding Roche Holding Ltd or give up 11.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GlaxoSmithKline PLC ADR  vs.  Roche Holding Ltd

GlaxoSmithKline PLC ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Roche Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Roche Holding Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with GlaxoSmithKline PLC and Roche Holding

The main advantage of trading using opposite GlaxoSmithKline PLC and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.

The idea behind GlaxoSmithKline PLC ADR and Roche Holding Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.